[go: up one dir, main page]

IE822026L - Imidazotetrazinones - Google Patents

Imidazotetrazinones

Info

Publication number
IE822026L
IE822026L IE822026A IE202682A IE822026L IE 822026 L IE822026 L IE 822026L IE 822026 A IE822026 A IE 822026A IE 202682 A IE202682 A IE 202682A IE 822026 L IE822026 L IE 822026L
Authority
IE
Ireland
Prior art keywords
carbon atoms
groups
group
denotes
alkyl
Prior art date
Application number
IE822026A
Other versions
IE53408B1 (en
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of IE822026L publication Critical patent/IE822026L/en
Publication of IE53408B1 publication Critical patent/IE53408B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

[3H]-Imidazo[5,1-d]-1,2,3,5-tetrazin-4-one derivatives of the formula: <IMAGE> in which R<1> denotes hydrogen or an alkyl, alkenyl or alkynyl group having up to 6 carbon atoms, each such group being unsubstituted or substituted by one to three substituents selected from halogen atoms, alkoxy, alkylthio, alkylsulphinyl and alkylsulphonyl groups having up to 4 carbon atoms and optionally substituted phenyl groups, or R<1> denotes a cycloalkyl group having 3 to 8 carbon atoms, and R<2> denotes a carbamoyl group, optionally N-substituted by one or two groups selected from alkyl and alkenyl groups having up to 4 carbon atoms and cycloalkyl groups having 3 to 8 carbon atoms, are novel therapeutically useful compounds having antineoplastic and immunomodulatory activity. [FR2511679A1]
IE2026/82A 1981-08-24 1982-08-23 Tetrazine derivatives IE53408B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8125791 1981-08-24

Publications (2)

Publication Number Publication Date
IE822026L true IE822026L (en) 1983-02-24
IE53408B1 IE53408B1 (en) 1988-11-09

Family

ID=10524141

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2026/82A IE53408B1 (en) 1981-08-24 1982-08-23 Tetrazine derivatives

Country Status (29)

Country Link
JP (1) JPS5843975A (en)
KR (1) KR890000094B1 (en)
AT (1) AT380256B (en)
AU (1) AU571430B2 (en)
BE (1) BE894175A (en)
CA (1) CA1197247A (en)
CH (1) CH655114A5 (en)
DE (2) DE19975037I2 (en)
DK (1) DK161147C (en)
ES (1) ES8400438A1 (en)
FI (1) FI73434C (en)
FR (1) FR2511679A1 (en)
GB (1) GB2104522B (en)
GE (1) GEP19960641B (en)
GR (1) GR76863B (en)
HU (1) HU186107B (en)
IE (1) IE53408B1 (en)
IL (1) IL66606A (en)
IT (1) IT1152505B (en)
LT (1) LT2436B (en)
LU (1) LU84347A1 (en)
LV (2) LV5511A3 (en)
NL (2) NL192739C (en)
NZ (1) NZ201668A (en)
OA (1) OA07174A (en)
SE (1) SE448543B (en)
SU (1) SU1447284A3 (en)
UA (1) UA5971A1 (en)
ZA (1) ZA826120B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260291A (en) * 1981-08-24 1993-11-09 Cancer Research Campaign Technology Limited Tetrazine derivatives
GB2125402B (en) * 1982-08-17 1985-11-13 May & Baker Ltd New tetrazine derivatives
FR2531958B1 (en) * 1982-08-17 1986-10-31 May & Baker Ltd NEW DERIVATIVES
US4517182A (en) * 1983-05-24 1985-05-14 Warner-Lambert Company 3-(Haloethyl)-4-oxopyrazolo-[5,1-d]-1,2,3,5-tetrazine-8-carboxamide composition
GB8616125D0 (en) * 1986-07-02 1986-08-06 May & Baker Ltd Compositions of matter
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
DK0866709T3 (en) * 1995-09-25 2007-03-19 Sanofi Aventis Us Llc 1,2,4-Benzotriazine oxide formulations
BRPI0417117A (en) 2003-12-30 2007-03-06 Chemagis Ltd crystallized temozolomide, crystallized temozolomide preparation process, pharmaceutical composition, method of producing medicament containing temozolomide and method of treating a medical condition for which thermozolomide is beneficial
ES2552338T3 (en) 2005-01-21 2015-11-27 Astex Therapeutics Limited Pharmaceutical compounds
PE20080695A1 (en) 2006-04-27 2008-06-28 Banyu Pharma Co Ltd DIHYDROPIRAZOLOPYRIMIDINONE DERIVATIVES AS KINASE WEEL INHIBITORS
JP2008081492A (en) 2006-08-31 2008-04-10 Banyu Pharmaceut Co Ltd Novel aminopyridine derivatives having selective inhibition of Aurora A
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
EP2213673B1 (en) 2007-10-23 2013-06-05 Msd K.K. Pyridone-substituted-dihydropyrazolopyrimidinone derivative
PE20091101A1 (en) * 2007-12-18 2009-07-26 Pharminox Ltd 3-SUBSTITUTED-4-OXO-3,4-DIHYDRO-IMIDAZO [5,1-d] [1,2,3,5-TETRACINE-8-CARBOXYL ACID AMIDES AND ITS USE
CN102256978A (en) * 2008-11-24 2011-11-23 利莱恩斯生命科学有限公司 Process for the preparation of tetrazine derivatives
US8481503B2 (en) 2009-03-06 2013-07-09 Merck Sharp & Dohme Corp. Combination cancer therapy with an AKT inhibitor and other anticancer agents
BRPI1011822A2 (en) 2009-06-23 2016-03-29 Pharminox Ltd "3-substituted-8-substituted-3h-imidazo [5,1-d] [1,2,3,5-tetrazin-4-one compounds and their application"
RU2462466C1 (en) * 2011-06-24 2012-09-27 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Substituted azolo[1,2,4,5]tetrazines - inhibitors of antibacterial serine-threonine protein kinases
WO2013055985A1 (en) 2011-10-12 2013-04-18 Children's Medical Center Corporation Combinatorial compositions and methods of treating hemoglobinopathies
EP3429571B1 (en) 2016-03-15 2025-10-08 Oryzon Genomics, S.A. Combinations of lsd1 inhibitors for use in the treatment of neoplastic diseases
KR101847342B1 (en) * 2017-05-08 2018-04-11 (주)센텍코리아 Wearable body fat burning measurement device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2932305A1 (en) * 1979-08-09 1981-02-26 Basf Ag Pyrrolo-, pyrazolo-, imidazo- and thiazolo-tetrazin-4-one derivs. - prepd. from amino-azole cpds. by diazotisation and reaction with isocyanate

Also Published As

Publication number Publication date
SE8204817D0 (en) 1982-08-23
AU571430B2 (en) 1988-04-21
DE3231255C2 (en) 1992-02-27
LT2436B (en) 1994-02-15
CA1197247A (en) 1985-11-26
DE3231255A1 (en) 1983-03-03
HU186107B (en) 1985-06-28
JPH045029B2 (en) 1992-01-30
KR890000094B1 (en) 1989-03-07
IL66606A0 (en) 1982-12-31
KR840001175A (en) 1984-03-28
IL66606A (en) 1987-07-31
NL192739B (en) 1997-09-01
SU1447284A3 (en) 1988-12-23
IT8222938A1 (en) 1984-02-23
FI822921A0 (en) 1982-08-23
BE894175A (en) 1983-02-23
IT8222938A0 (en) 1982-08-23
LV5621A3 (en) 1994-05-10
ATA319182A (en) 1985-09-15
JPS5843975A (en) 1983-03-14
SE8204817L (en) 1983-02-25
FR2511679A1 (en) 1983-02-25
NL990010I1 (en) 1999-07-01
ES515176A0 (en) 1983-11-01
ES8400438A1 (en) 1983-11-01
AT380256B (en) 1986-05-12
DE19975037I2 (en) 2001-06-13
GR76863B (en) 1984-09-04
NZ201668A (en) 1985-08-16
AU8749382A (en) 1983-03-03
NL990010I2 (en) 1999-09-01
FI822921L (en) 1983-02-25
GB2104522A (en) 1983-03-09
IT1152505B (en) 1987-01-07
SE448543B (en) 1987-03-02
OA07174A (en) 1984-04-30
DK161147C (en) 1991-11-18
FR2511679B1 (en) 1985-02-01
FI73434B (en) 1987-06-30
NL192739C (en) 1998-01-06
NL8203286A (en) 1983-03-16
UA5971A1 (en) 1994-12-29
LV5511A3 (en) 1994-03-10
CH655114A5 (en) 1986-03-27
DK161147B (en) 1991-06-03
LU84347A1 (en) 1983-06-07
ZA826120B (en) 1983-07-27
GB2104522B (en) 1985-06-12
GEP19960641B (en) 1996-11-15
DK377882A (en) 1983-02-25
FI73434C (en) 1987-10-09
IE53408B1 (en) 1988-11-09

Similar Documents

Publication Publication Date Title
IE822026L (en) Imidazotetrazinones
EP1069111A4 (en) Indole derivatives with antiviral activity
CA2165819A1 (en) Dc-89 derivatives
CA2396738A1 (en) Thiazole derivatives as active superoxide radical inhibitors
AU6052594A (en) New heterocyclic compounds
IE801806L (en) ß-CARBOLIN-3-CARBOXYLIC ACID DERIVATIVES
GR3023219T3 (en) Pyrazolopyridine compounds and processes for preparation thereof
IE780625L (en) Imidazo-triazines
IE812460L (en) Substituted azabicyclo-octane-carboxylic acids
IE810654L (en) Azetidinone derivatives.
MY101841A (en) Insecticidal trifluormethyl alkane derivatives.
IE800449L (en) Pyrazoline derivatives.
AU575342B2 (en) Gamma - butyrolactone derivatives
AU4149293A (en) 4-iminoquinolines, processes for their preparation, and their use
ZA864235B (en) 1-aryl-5-alkoximinoalkylamino-pyrazoles
AU557559B2 (en) 7 - acylthio-15,16-methylene-3-oxo-17 - pregna-1,4-diene- 21,17-carbolactones
IE831840L (en) Cardiotonic agents
IE801729L (en) A morpholine derivative
CA2092919A1 (en) Epoxysuccinamic acid derivatives
IE852246L (en) Penicillins
IE41462L (en) Piperidyl-methylenedioxybenzene derivatives.
EP0485890A3 (en) Use of 2,3-disubstituate 1-azolyl-propane for inhibiting the pathogenic growth phase of dimorph yeast cell
GB1556877A (en) Imidazothiazoles and thiazolopyrimidines
IE830282L (en) Ergot alkaloids
IE790163L (en) Thieno-pyridines

Legal Events

Date Code Title Description
SPCF Request for grant of supplementary protection certificate

Free format text: SPC 8/99, 19990513

SPCG Supplementary protection certificate granted

Free format text: SPC008/1999, 20020429, EXPIRES: 20020823

MK9A Patent expired